BDBM350522 1-[4-methyl-2,5-dioxo-4-(2- phenylethyl)imidazolidin-1-yl]-3- phenylurea::US10208071, Table 2.3::US10434112, Table 2.3::US10799518, Structure TABLE 2.3

SMILES CC1(CCc2ccccc2)NC(=O)N(NC(=O)Nc2ccccc2)C1=O

InChI Key InChIKey=CJHLQOOKWGKLJY-UHFFFAOYSA-N

Data  3 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 350522   

TargetN-formyl peptide receptor 2(Human)
Allergan

US Patent
LigandPNGBDBM350522(1-[4-methyl-2,5-dioxo-4-(2- phenylethyl)imidazolid...)
Affinity DataEC50:  2.23E+5nMAssay Description:HEK-Gα16 cells stably expressing the human FPR2 receptor was utilized. Cells were plated into 384-well poly-D-lysine coated plates at a density ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/21/2019
Entry Details
Go to US Patent

TargetN-formyl peptide receptor 2(Human)
Allergan

US Patent
LigandPNGBDBM350522(1-[4-methyl-2,5-dioxo-4-(2- phenylethyl)imidazolid...)
Affinity DataEC50:  223nMAssay Description:HEK-Gα16 cells stably expressing the human FPR2 receptor was utilized. Cells were plated into 384-well poly-D-lysine coated plates at a density ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/16/2020
Entry Details
Go to US Patent

TargetN-formyl peptide receptor 2(Human)
Allergan

US Patent
LigandPNGBDBM350522(1-[4-methyl-2,5-dioxo-4-(2- phenylethyl)imidazolid...)
Affinity DataEC50:  223nMAssay Description:HEK-Gα16 cells stably expressing the human FPR2 receptor was utilized. Cells were plated into 384-well poly-D-lysine coated plates at a density ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
Go to US Patent